SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Real Asian Hours

$CHINAWINS is trending amid community excitement, with many noting the strong branding and momentum. The crypto is seeing increased attention from Phantom Wallet users, who are actively 'stacking bags.' However, some users are expressing skepticism, labeling it a potential scam or pump-and-dump.

Zoracles

Zoracles ($ZORA) is trending as community members discuss its potential listing on additional exchanges and speculate on future price movements. Bullish sentiment is fueled by its association with a social media platform where every post can be tokenized, attracting attention in the crypto space. Some traders are closely watching for entry points, with many believing $ZORA has strong long-term potential.

Pagaya Technologies Ltd. engages in the development of AI and data networks for the financial industry. Its product deploys data science, machine learning and AI technology to evaluate the customers' applications in real time. The company was founded by Gal Krubiner, Sanjiv Das, Yahav Yulzari, and Avital Pardo on March 20, 2016 and is headquartered in New York, NY.

Pagaya Technologies Ltd - Ordinary Shares - Class A

Pagaya Technologies Ltd

PGY is trending amidst discussions about its volatility, potential for growth, and recent market behavior, with community members weighing bullish and bearish perspectives. Analysts' price target adjustments and debates around earnings outlook are fueling the conversation. Some investors are expressing concerns about potential portfolio losses, while others remain optimistic about the company's long-term prospects and AI-driven approach.

Aclarion, Inc. is a healthcare technology company, which engages in the provision of Magnetic Resonance Spectroscopy (MRS), and a proprietary biomarker to optimize clinical treatments. It utilizes Artificial Intelligence to assist in quality control processes that flag spectroscopy data indicative of a poor MRS study. It offers NOCISCAN Suite, a revolutionary software suite that works with existing high field Magnetic Resonance systems and Magnetic Resonance Spectroscopy pulse sequence packages using an optimized protocol to conduct MRS exams of lumbar discs. The company was founded by James C. Peacock, David S. Bradford, and Jeffrey Lotz in 2008 and is headquartered in Broomfield, CO.

Aclarion Inc

Aclarion ($ACON) is trending due to community speculation about a potential short squeeze and significant gains, possibly as early as Monday. The stock's low float is a key talking point, with some investors hoping for a rapid price increase, while others cite concerns about the company's history of reverse splits and potential dilution.

Bitcoin is the first successful internet money based on peer-to-peer technology; whereby no central bank or authority is involved in the transaction and production of the Bitcoin currency. It was created by an anonymous individual/group under the name, Satoshi Nakamoto. The source code is available publicly as an open source project, anybody can look at it and be part of the developmental process.  Bitcoin is changing the way we see money as we speak. The idea was to produce a means of exchange, independent of any central authority, that could be transferred electronically in a secure, verifiable and immutable way. It is a decentralized peer-to-peer internet currency making mobile payment easy, very low transaction fees, protects your identity, and it works anywhere all the time with no central authority and banks.  Bitcoin is designed to have only 21 million BTC ever created, thus making it a deflationary currency. Bitcoin uses the SHA-256 hashing algorithm with an average transaction confirmation time of 10 minutes. Miners today are mining Bitcoin using ASIC chip dedicated to only mining Bitcoin, and the hash rate has shot up to peta hashes.  Being the first successful online cryptography currency, Bitcoin has inspired other alternative currencies such as Litecoin, Peercoin, Primecoin, and so on.  The cryptocurrency then took off with the innovation of the turing-complete smart contract by Ethereum which led to the development of other amazing projects such as EOS, Tron, and even crypto-collectibles such as CryptoKitties.

Bitcoin

Bitcoin is trending amid discussions about a recent market dip and potential impacts from trade tensions involving China. Community members are debating whether this is a buying opportunity or the start of a larger correction, with some highlighting potential manipulation and others emphasizing Bitcoin's long-term value proposition. Concerns about leveraged positions and potential liquidations are also circulating.

ONDO is a DeFi primitive that enables users to originate risk-isolated, fixed yield loans backed by yield-generating crypto-assets. It's unique because it's a permissionless protocol that allows users to interact on a peer-to-pool basis with no intermediaries.

Ondo

Ondo is trending as the community discusses its potential in the Real World Asset (RWA) tokenization space and possible connections to traditional finance giants. Conversations revolve around its long-term prospects and utility, with some anticipating significant growth. Recent news and partnerships may be acting as catalysts, though opinions are divided on its immediate price action.

UWM Holdings Corp. is a wholesale mortgage lender, which underwrites and provides closing documentation for residential mortgage loans originated by independent mortgage brokers, correspondents, small banks and local credit unions. The firm provides independent mortgage advisors with a set of technologically driven tools and a value proposition that enables them to offer borrowers that meet the credit rating standards compelling financing alternatives. The company was founded in 1986 and is headquartered in Pontiac, MI.

UWM Holdings Corporation - Ordinary Shares - Class A

UWMC is trending as investors discuss its upcoming earnings and potential benefits from falling rates, particularly in relation to derivative assets and Q3 performance. The community is weighing the impact of market dynamics and interest rate trends on the company's future profitability. Some are also closely monitoring the progress of a settlement related to past claims.

Unusual Machines, Inc. is a development stage technology company, which engages in the provision of drone solutions with a focus on first-person view (FPV) technology. It offers products to entertainment, recreation, and competitive racing industries. The company was founded on July 11, 2019, and is headquartered in Orlando, FL.

Unusual Machines Inc

Unusual Machines, Inc.

Unusual Machines is trending as the community discusses its connection to Donald Trump Jr. and the company's potential role in upcoming drone contracts. Conversations also highlight the broader drone sector and Unusual Machine's position as a component supplier, with some anticipating significant growth and others expressing concerns about dilution and revenue.

American Battery Technology Co. is a technology company, which engages in the development and marketing of lithium-ion batteries. Its projects include recycling plant, United States Advanced Battery Consortium (USABC), and Tonopah flats. The company was founded on October 6, 2011 and is headquartered in Reno, NV.

American Battery Technology Company

American Battery Technology Company is trending as community members discuss the potential impacts of China's export restrictions on lithium batteries and materials, with some anticipating increased government support and partnerships for domestic suppliers. Chatter revolves around the upcoming PFS report and potential funding, while some express concerns about possible pullbacks and the influence of market makers. Overall, the sentiment appears bullish, with many highlighting ABAT's potential role in securing America's metal supply chain.

Assemble’s AI agent, News3(NS3), was developed with the goal of revolutionizing Web 3.0 journalism. NS3 delivers crypto and global economic trends quickly and clearly, and leverages advanced AI reasoning capabilities to analyze these trends, enabling market participants to make data-driven decisions. In particular, NS3 utilizes OpenAI’s latest reasoning model as its core engine to analyze crypto and economic trends, providing a range of insights including market psychology, past case analysis, future predictions, ripple effects, and investment strategies in 12 languages.

Assemble Protocol

Assemble Protocol ($ASM) is trending as traders discuss its potential, particularly around AI narratives and anticipation for a possible Binance listing. The community is closely watching for a breakout, speculating on potential price targets and highlighting whale activity. Some traders express frustration with price fluctuations, while others remain optimistic about long-term gains and potential news.

statis crypto Watchlist

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Investors Heavily Search Novavax, Inc. (NVAX): Here is What You Need to Know

Recently, Zacks.com users have been paying close attention to Novavax (NVAX). This makes it worthwhile to examine what the stock has in store.

Novavax (NVAX) Stock Slides as Market Rises: Facts to Know Before You Trade

Novavax (NVAX) closed the most recent trading day at $9.08, moving 4.02% from the previous trading session.

Novavax (NVAX) Exceeds Market Returns: Some Facts to Consider

The latest trading day saw Novavax (NVAX) settling at $8.67, representing a +1.17% change from its previous close.

Novavax, Inc. (NVAX) on Tuesday said that it has amended its collaboration and license agreement with Sanofi (SNY) to include the use of its Matrix-M adjuvant in Sanofi's pandemic influenza vaccine candidate program.The amendment of the agreement allows for the use of Matrix-M in early-stage development of Sanofi's pandemic influenza vaccine candidate. The two players will negotiate license rates and financial terms if the program enters late-stage study, Novavax <a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://ir.novavax.com/press-releases/2025-09-30-Novavax-Announces-Progress-on-Sanofi-Agreement">said</a>.Matrix-M is Novavax's proprietary adjuvant that can be added to a vaccine to stimulate a stronger immune response and is currently used in globally approved vaccines. Sanofi is currently exploring additional opportunities with Matrix-M, Novavax said.<a href="https://stocktwits.com/symbol/NVAX">NVAX stock</a> traded 1.4% lower on Tuesday morning and was among the top trending tickers on Stocktwits. On Stocktwits, retail sentiment around NVAX stock stayed within the ‘bearish’ territory over the past 24 hours, while message volume stayed at ‘low’ levels.A Stocktwits user opined that the agreement is a long-term payout play.<stembedurl>https://stocktwits.com/DifferentRadar/message/630462629</stembedurl>The new amendment adds to the terms of the original agreement between the two companies, dated May 2024. Under the agreement, Novavax is entitled to receive up to $200 million for the first four products created by Sanofi utilizing its Matrix-M adjuvant, and up to $210 million in milestone payments for each product including Matrix-M thereafter. Novavax is also eligible to receive royalties for all Sanofi products utilizing Matrix-M.Sanofi is Novavax’s biggest partner. In the second quarter, the $199 million received from Sanofi accounted for over 83% of Novavax’s total revenue of $239 million.NVAX stock is up by 5% this year but down by 33% over the past 12 months.Read also:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/tesla-gets-price-target-hike-from-canaccord/chDD7JrR3Bq">Tesla Gets A Price Target Hike From Canaccord: Retail Sees Stock Touching New Highs</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

In this photo illustration a covid-19 vaccine is seen with the Novavax logo in the background. (Photo Illustration by Nikos Pekiaridis/NurPhoto via Getty Images)

Novavax Amends Deal With Sanofi, Broadens Partnership

The amendment of the agreement allows for the use of Matrix-M in early-stage development of Sanofi's pandemic influenza vaccine candidate.

Equity

The amendment of the agreement allows for the use of Matrix-M in early-stage development of Sanofi's pandemic influenza vaccine candidate.


Here's Why Novavax (NVAX) is a Strong Momentum Stock

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

Here is What to Know Beyond Why Novavax, Inc. (NVAX) is a Trending Stock

Novavax (NVAX) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.

Novavax (NVAX) Declines More Than Market: Some Information for Investors

Novavax (NVAX) concluded the recent trading session at $8.68, signifying a -2.2% move from its prior day's close.

Here's Why Novavax (NVAX) Fell More Than Broader Market

Novavax (NVAX) closed at $8.39 in the latest trading session, marking a -1.99% move from the prior day.

MRNA Stock Rises as Updated COVID-19 Jab Shows Strong Immune Response

Moderna jumps after its updated formulation of Spikevax shows an over 8-fold increase in neutralizing antibodies against the LP.8.1 COVID-19 variant in phase IV study.

COVID-19 Vaccine Stocks Fall on Reports Linking Shots to Child Deaths

MRNA, BNTX, PFE and NVAX stocks fall as health officials reportedly plan to link COVID-19 vaccines to child deaths ahead of a key CDC meeting.

Novavax, Inc. Is a biotechnology company, which engages in the discovery, development, and commercialization of recombinant vaccines. The company was founded in 1987 and is headquartered in Gaithersburg, MD.

Novavax, Inc.

Will JP Morgan Chase ($JPM) beat quarterly earnings?  
 
*Powered by Polymarket

Stocktwits

JPMorgan Chase & Co

) beat quarterly earnings?  
 
*Powered by Polymarket

Fiscal Period	Estimated	Reported	Surprise	Result
Q3 '25	-$0.54	--	--	N/A
Q2 '25	-$0.04	$0.62	1849.19%	BEAT
Q1 '25	-$0.42	$2.93	792.13%	BEAT
Q4 '24	-$0.43	-$0.51	-18.60%	MISSED
Q3 '24	-$0.83	-$0.76	8.31%	BEAT

NVAX
Novavax Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Upcoming Earnings: Q3 '25

Historical Earnings

Latest NVAX News

NVAXNovavax Inc